{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T01:48:11Z","timestamp":1719798491133},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,11,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Intracavernous pharmacotherapy is one of the most common treatment modalities of erectile dysfunction (ED). There are different drugs that are used for intracavernous injection including papaverine, phentolamine, prostaglandins E1, phenoxybenzamine, and moxisylate.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>The aim of this study is to evaluate the efficacy of chlorpromazine as an intracavernous vasoactive agent alone or with other drugs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This study was performed on 50 patients presenting to our department complaining of ED. Patients were divided into three groups according to the type of intracavernous drug injected. Group A included 20 patients who received an intracavernous injection of 1 mL bimix (30 mg papaverine + 1 mg phentolamine) followed a week later by intracavernous test dose using a 1 mL mixture of papaverine and chlorpromazine (30 mg papaverine + 2.5 mg chlorpromazine). Group B included 20 patients who received an intracavernous injection of 1 mL trimix (30 mg papaverine + 1 mg phentolamine + 10 \u00b5g PGE1). A week later they received another intracavernous test dose using a 1 mL mixture of papaverine, PGE1, and chlorpromazine (30 mg papaverine + 2.5 mg chlorpromazine + 10 \u00b5g PGE1). Group C included 10 patients who received various intracavernous injections of chlorpromazine in doses 1 mg, 2 mg, 5 mg, and 10 mg.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>There was no significant difference in erection response and erection duration between phentolamine and chlorpromazine. Prolonged erection occurred in two patients of group B and postural hypotension occurred in three patients of group C.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Chlorpromazine can be used as an intracavernous vasoactive agent; it is similar to phentolamine in efficacy and short-term side effect profile.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.04044.x","type":"journal-article","created":{"date-parts":[[2004,10,13]],"date-time":"2004-10-13T14:00:40Z","timestamp":1097676040000},"page":"310-313","source":"Crossref","is-referenced-by-count":8,"title":["Intracavernous Chlorpromazine Versus Phentolamine: A Double-Blind Clinical Comparative Study"],"prefix":"10.1093","volume":"1","author":[{"given":"Rany","family":"Shamloul","sequence":"first","affiliation":[{"name":"Department of Andrology, Sexology and STDs, Cairo University , Cairo , Egypt"},{"name":"Department of Phsyiology, University of Saskatchewan , Saskatoon , Canada"},{"name":"Elzeraeen Hospital , Cairo , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"El-Dakhly","sequence":"additional","affiliation":[{"name":"Department of Andrology, Sexology and STDs, Cairo University , Cairo , Egypt"},{"name":"Elzeraeen Hospital , Cairo , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein","family":"Ghanem","sequence":"additional","affiliation":[{"name":"Department of Andrology, Sexology and STDs, Cairo University , Cairo , Egypt"},{"name":"Elzeraeen Hospital , Cairo , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amr","family":"Gadallah","sequence":"additional","affiliation":[{"name":"Department of Andrology, Sexology and STDs, Cairo University , Cairo , Egypt"},{"name":"Elzeraeen Hospital , Cairo , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hany","family":"Mokhtar","sequence":"additional","affiliation":[{"name":"Department of Phsyiology, University of Saskatchewan , Saskatoon , Canada"},{"name":"Elzeraeen Hospital , Cairo , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2004,11,1]]},"reference":[{"key":"2024032600065080600_bib1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5347(17)34871-1","article-title":"Impotence and its medical and psychosocial correlates: Results of Massachusetts Male Aging Study","volume":"151","author":"Feldman","year":"1994","journal-title":"J Urol"},{"key":"2024032600065080600_bib2","first-page":"529","article-title":"Priapism","author":"Serels","year":"1999:","journal-title":"Textbook of erectile dysfunction."},{"key":"2024032600065080600_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0022-5347(17)38316-7","article-title":"Intracavernous self-injection of vasoactive drugs in the treatment of impotence","volume":"145","author":"Virag","year":"1991","journal-title":"J Urol"},{"key":"2024032600065080600_bib4","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1192\/bjp.143.4.332","article-title":"Cavernosal alpha blockade: a new technique for investigating and treating erectile impotence","volume":"143","author":"Brindley","year":"1983","journal-title":"Br J Psychiatry"},{"key":"2024032600065080600_bib5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0024-3205(89)90194-X","article-title":"Effect of moxisylate hydrochloride on isolated human penile corpus cavernosum tissue","volume":"44","author":"Imagawa","year":"1989","journal-title":"Life Sci"},{"issue":"1 suppl","key":"2024032600065080600_bib6","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1038\/sj.ijir.3900808","article-title":"Current status of local penile therapy","volume":"14","author":"Montorsi","year":"2002","journal-title":"Int J Impot Res"},{"key":"2024032600065080600_bib7","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/0090-4295(93)90272-C","article-title":"Effectiveness and safety of multidrug Intracavernous therapy for vasculogenic impotence","volume":"42","author":"Montorsi","year":"1993","journal-title":"J Urol"},{"key":"2024032600065080600_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-5347(17)48774-X","article-title":"Autoinjection of corpus cavernosum with a vasoactive drug combination for vasculogenic impotence","volume":"133","author":"Zorgniotti","year":"1985","journal-title":"J Urol"},{"key":"2024032600065080600_bib9","first-page":"113","article-title":"Chlorpromazine: A good substitute drug for phentolamine\u2014a follow up study of 174 patients","volume":"8","author":"Braga","year":"1996","journal-title":"Int J Impot Res"},{"key":"2024032600065080600_bib10","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0022-5347(17)41033-0","article-title":"Standardized evaluation of erectile dysfunction in 95 consecutive patients","volume":"141","author":"Gerstenberg","year":"1989","journal-title":"J Urol"},{"key":"2024032600065080600_bib11","first-page":"143","article-title":"A clinical study of the erection-inducing effects of intracavernosal chlorpromazine","volume":"8","author":"Kulkarni","year":"1996","journal-title":"Int J Impot Res"},{"issue":"1 suppl","key":"2024032600065080600_bib12","first-page":"D114","article-title":"An old alpha blocker drug with a new destination: Comparative clinical study of chlorpromazinen versus phentolamine effects in intracavernous injections for erectile dysfunction treatment","volume":"6","author":"Marques","year":"1994","journal-title":"Int J Impot Res"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174360951531078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174360951531078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/1\/3\/310\/47522187\/jsm_1_3_310.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/1\/3\/310\/47522187\/jsm_1_3_310.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T01:03:38Z","timestamp":1711415018000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/1\/3\/310\/6863008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,1]]},"references-count":12,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2004,11,1]]},"published-print":{"date-parts":[[2004,11,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.04044.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,11]]},"published":{"date-parts":[[2004,11,1]]}}}